Original ResearchPublished 7 May 2026Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authoritiesCarlos G. Bernaus · Maria Lilia BournissenFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1821686